首页> 外国专利> Recombinant gene drug of adenoviral vector and P53 gene for treating proliferative diseases

Recombinant gene drug of adenoviral vector and P53 gene for treating proliferative diseases

机译:腺病毒载体和P53基因的重组基因药物治疗增生性疾病

摘要

A kind of recombinant gene medicine of adenovirus vector and gene p53 which can treat proliferative diseases is a confusion sequence constructed from adenovirus vector and human tumor inhibition gene p53 expression kit. In the present invention, we made homologous recombination of adenovirus vector with human gene p53 in procaryotic cells (E. coli), then obtained the recombinant gene medicine of adenovirus vector and human gene p53 expression kit. The human p53 gene expression kit is a characteristic sequence consisting of promoter-p53 cDNA-polyadenine nucleotide. The medicine can be used to prepare clinic gene therapeutic products for treating proliferative disease such as cheloid.
机译:由腺病毒载体和人肿瘤抑制基因p53表达试剂盒构建的混淆序列是一种可以治疗增生性疾病的腺病毒载体和p53基因重组基因药物。在本发明中,我们在原核细胞(大肠杆菌)中使腺病毒载体与人基因p53同源重组,然后获得了腺病毒载体的重组基因药物和人基因p53表达试剂盒。人p53基因表达试剂盒是由启动子-p53 cDNA-聚腺嘌呤核苷酸组成的特征序列。该药物可用于制备临床基因治疗产品,用于治疗增生性疾病,例如胶体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号